DAILYZ HEALTH NEWS

October 4, 2026 Evan Vega

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.

Health

October 4, 2026 Evan Vega

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

The U.S. HHS awarded $247.9 million in grants to expand mental health and addiction treatment services nationwide.

Health

October 3, 2026 Evan Vega

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

A Doctors Without Borders worker infected with Bundibugyo virus during DRC Ebola outbreak was evacuated to the Netherlands for specialized treatment.

Health

September 16, 2026 Evan Vega

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

The FDA authorized emergency use of Capstar and generic Nitenpyram to prevent and treat New World screwworm in dogs and cats nationwide.

Health

September 13, 2026 Evan Vega

FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children

The FDA approved Zanvastro, the first drug to treat Alexander disease by targeting abnormal GFAP buildup in pediatric and adult patients.

Health

September 13, 2026 Evan Vega

CDC and state health officials investigate multistate Listeria outbreak linked to soft-ripened cheese sold at Whole Foods Market, prompting nationwide recall and public warning to high-risk consumers

CDC and state officials investigated a 2013 multistate Listeria outbreak linked to Crave Brothers soft-ripened cheeses sold at Whole Foods, leading to a recall.

Health

August 29, 2026 Evan Vega

FDA Approves Roivant’s Lisraya (brepocitinib) as First Oral Drug for Dermatomyositis

The FDA approved Roivant’s Lisraya (brepocitinib), the first oral dual TYK2/JAK1 inhibitor, to treat dermatomyositis in adults.

Health

August 28, 2026 Evan Vega

FDA Recalls 12 Herbal Supplements Over Hidden Drug Ingredients

GURU INC. recalled Infla-650 herbal supplement after FDA found undeclared drugs acetaminophen, diclofenac, and phenylbutazone in the capsules.

Health

August 27, 2026 Evan Vega

Pennsylvania records its first measles deaths in 35 years

Pennsylvania reports its first measles deaths in 35 years, with two unvaccinated individuals dying amid a 393-case outbreak in 29 counties.

Health

August 27, 2026 Evan Vega

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

The FDA approved LISRAYA (brepocitinib), the first oral TYK2/JAK1 inhibitor for treating adult dermatomyositis, on August 27, 2026.